EHRA Expert Consensus Statement on the management of cardiovascular implantable electronic devices in patients nearing end of life or requesting withdrawal of therapy

Luigi Padeletti, David O. Arnar, Lorenzo Boncinelli, Johannes Brachman, John A. Camm, Jean Claude Daubert, Sarah Kassam, Luc Deliens, Michael Glikson, David Hayes, Carsten Israel, Rachel Lampert, Trudie Lobban, Pekka Raatikainen, Gil Siegal, Panos Vardas, Paulus Kirchhof, Rüdiger Becker, Francisco Cosio, Peter LohStuart Cobbe, Andrew Grace, John Morgan

Research output: Contribution to journalArticle

Abstract

The purpose of this Consensus Statement is to focus on implantable cardioverter-defibrillator (ICD) deactivation in patients with irreversible or terminal illness. This statement summarizes the opinions of the Task Force members, convened by the European Heart Rhythm Association (EHRA) and the Heart Rhythm Society (HRS), based on ethical and legal principles, as well as their own clinical, scientific, and technical experience. It is directed to all healthcare professionals who treat patients with implanted ICDs, nearing end of life, in order to improve the patient dying process. This statement is not intended to recommend or promote device deactivation. Rather, the ultimate judgement regarding this procedure must be made by the patient (or in special conditions by his/her legal representative) after careful communication about the deactivation's consequences, respecting his/her autonomy and clarifying that he/she has a legal and ethical right to refuse it. Obviously, the physician asked to deactivate the ICD and the industry representative asked to assist can conscientiously object to and refuse to perform device deactivation.

Original languageEnglish
Pages (from-to)1480-1489
Number of pages10
JournalEuropace
Volume12
Issue number10
DOIs
Publication statusPublished - Oct 2010

Keywords

  • CIED management
  • End of life patients
  • ICD deactivation

ASJC Scopus subject areas

  • Cardiology and Cardiovascular Medicine
  • Physiology (medical)

Fingerprint Dive into the research topics of 'EHRA Expert Consensus Statement on the management of cardiovascular implantable electronic devices in patients nearing end of life or requesting withdrawal of therapy'. Together they form a unique fingerprint.

  • Cite this

    Padeletti, L., Arnar, D. O., Boncinelli, L., Brachman, J., Camm, J. A., Daubert, J. C., Kassam, S., Deliens, L., Glikson, M., Hayes, D., Israel, C., Lampert, R., Lobban, T., Raatikainen, P., Siegal, G., Vardas, P., Kirchhof, P., Becker, R., Cosio, F., ... Morgan, J. (2010). EHRA Expert Consensus Statement on the management of cardiovascular implantable electronic devices in patients nearing end of life or requesting withdrawal of therapy. Europace, 12(10), 1480-1489. https://doi.org/10.1093/europace/euq275